''In another informative Clinical Trials Science Forum in May, ACW CMO Dr Dana Hilt and guest
experts explored the unique properties of Xanamem for the potential treatment of cognitive
impairment in multiple diseases. Click here to view the video recording''.
Also,the trial participant side of things is gearing up in Australia and America.
- Forums
- ASX - By Stock
- Ann: ACW June 2024 quarterly activity report & Appendix 4C
''In another informative Clinical Trials Science Forum in May,...
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACW (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.6¢ |
Change
0.001(4.00%) |
Mkt cap ! $76.57M |
Open | High | Low | Value | Volume |
2.5¢ | 2.7¢ | 2.5¢ | $192.6K | 7.531M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 4201185 | 2.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.6¢ | 8694 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 4113185 | 0.025 |
23 | 6288803 | 0.024 |
25 | 5822139 | 0.023 |
14 | 8036010 | 0.022 |
18 | 2756880 | 0.021 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 4207443 | 6 |
0.028 | 1031405 | 4 |
0.029 | 4642413 | 8 |
0.030 | 2614680 | 7 |
0.031 | 751771 | 3 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |